On December 1, 2021 Compass, Inc. (NYSE: COMP), a leading technology-enabled residential real estate brokerage, reported that it will participate in the following investor conferences (Press release, Compass Therapeutics, DEC 1, 2021, View Source [SID1234596365]). Robert Reffkin, Founder, Chairman, and Chief Executive Officer, and Kristen Ankerbrandt, Chief Financial Officer, will both present at:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

UBS Global Technology, Media and Telecommunications Conference on Tuesday, December 7, 2021 at 5:00 p.m. ET.
Barclays Global Technology, Media and Telecommunications Conference on Wednesday, December 8, 2021 at 12:40 p.m. ET.
Both live and replay versions of the presentations will be available under the Events & Presentations section of the Compass Investor Relations website, View Source